SCHEMBL15077679

SCHEMBL15077679

COc1ccc(C2Oc3cc(C)cc(OC)c3C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
LMNA P02545 1/20 0.45
MAOB P27338 1/20 0.44
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
ABCB1 P08183 3/20 0.43
CBS P35520 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15077681 1.00 ALDH1A1 (0.47) ALDH1A1NPC1RAB9ALMNAMAOB
SCHEMBL10054661 0.89 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ALMNAMEN1
SCHEMBL30725970 0.89 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ALMNAMEN1
SCHEMBL6324673 0.89 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ALMNAMEN1
SCHEMBL30725971 0.80 ALDH1A1 (0.55) ALDH1A1MAPTABCB1KDM4ECYP3A4
SCHEMBL2629461 0.80 ALDH1A1 (0.55) ALDH1A1MAPTABCB1KDM4ECYP3A4
SCHEMBL30966448 0.80 ALDH1A1 (0.55) ALDH1A1MAPTABCB1KDM4ECYP3A4
SCHEMBL29169330 0.80 ALDH1A1 (0.63) ALDH1A1ABCB1KDM4ECYP3A4HPGD
SCHEMBL15373706 0.78 KCNH2 (0.57) ALDH1A1MAOBCYP19A1KCNH2TRPV1
SCHEMBL18104369 0.78 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206100-B2 Route to synthetic analogues of Rocaglamide and Aglafoline using cascade transformations initiated by oxy-cope rearrangement of bis-alkynes The Florida State University Research Foundation, Inc. (US) 2015-12-08 US disclosed
US-20130165683-A1 NEW ROUTE TO SYNTHETIC ANALOGUES OF ROCAGLAMIDE AND AGLAFOLINE USING CASCADE TRANSFORMATIONS INITIATED BY OXY-COPE REARRANGEMENT OF BIS-ALKYNES THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION INC. 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165683-A1 NEW ROUTE TO SYNTHETIC ANALOGUES OF ROCAGLAMIDE AND AGLAFOLINE USING CASCADE TRANSFORMATIONS INITIATED BY OXY-COPE REARRANGEMENT OF BIS-ALKYNES COASY, RIMKLA, ACSL3 ALDH1A1 1262/4885NPC1 1681/4885RAB9A 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.